FDA Asks For Input On Therapeutic Equivalence

Comments On TE Codes And Patents Could Lead To 'Orange Book' Changes

 
• By Derrick Gingery
  
FDA words adn building icon
The FDA also seeks comments on the potential changes to 'Orange Book' patent listing practices • Source: Shutterstock

More from Regulation

More from Policy & Regulation